Fenofibrate has shown to reduce major cardiovascular events and slow angiographic progression of coronary atherosclerosis. Its postulate mechanism of action is through adwation of peroxlsomal proliferator-activated receptor-alpha, a nuclear transcription factor that controls a van&y of cellular functions. We investigated the antiatherogenic effects of fenofibrate on previously established experimental atherosclerotic (AT) lesions. Method AT-lesions were induced in NZW rabbits (n=24) by a combination of double balloon-mjury and g-month hypercholesterolemlc (HC) diet. At the end of the AT-inductton period all rabbits underwent MRI and 7 of them were sacrificed, processed for histology, and served as AT-control. The remaining animals were randomized into 3 groups: [l] resuming standard chow (n=5), [2] HC-diet+placebo (n=6) and [3] HC-diet+fenofibrate (n=6). Rabbits underwent an additional MRI after 6 months of treatment, and were then sacrificed for histopathology. Results MRI showed that all groups had similar vessel wall area (VWA) at randomization. Significant increase in VWA was seen in the HC-diet+placebo group (15%*4%. p=O.O07 vs. baseline). In the group resuming standard chow, progression was abolished (-2.5+3%, ~~0.37 vs. baseline). The fenofibrate group had significant plaque regression (-11+4%, p=O.O41) despite maintalned HC-diet. Plasma lipid levels were normalized in standard chow group, whereas they remamed elevated m both, the HC-diet+placebo and HC-diet+fenofibrate groups. Hlstopathological analysis, to define vascular biology of the different treatment groups, IS under investigation.
Introduction:
Fenofibrate has shown to reduce major cardiovascular events and slow angiographic progression of coronary atherosclerosis. Its postulate mechanism of action is through adwation of peroxlsomal proliferator-activated receptor-alpha, a nuclear transcription factor that controls a van&y of cellular functions. We investigated the antiatherogenic effects of fenofibrate on previously established experimental atherosclerotic (AT) lesions.
Method AT-lesions were induced in NZW rabbits (n=24) by a combination of double balloon-mjury and g-month hypercholesterolemlc (HC) diet. At the end of the AT-inductton period all rabbits underwent MRI and 7 of them were sacrificed, processed for histology, and served as AT-control. The remaining animals were randomized into 3 groups: [ months the changes in E-selectm and P-selectin were strongly correlated with the decrease in aortic plaque volume (p=O.Ol).
Conclusions:
Baseline aortic atherosclerottc plaque burden by TEMRI correlated better with serum levels of E-selectin and P-selectin than with serum inflammatory markers or cholesterol values. After 6 months of statin therapy, changes in P-selectin and E-selechn were strongly correlated with the reduction in aortic plaque volume as measured by TEMRI. Because of the predilection sites of plaques and the observed anti-atherogenic effects of statins, the aim of this study was to investigate the potential of statins to operate at specific locations.
Methods
and Results MR images of the thoracic descending aorta of 9 asymptomatic hypercholesteremic patients (15 lesions) were acquired at baseline and 24 months after Itpid-lowering therapy by simvastatm. Contours of cross-sectional images were manually traced at the inner and outer vessel wall. At each cross section local wall thicknesses (LWT) were derived; the average wall thickness of each quadrant was calculated and the circumferential location and axial location as measured as distance from the arch (DA)
were documented. Cross SectIons were divided into 4 groups based on the circumferential (left or right side of the aorta) and axial location (DA> 6 cm or DA< 6cm). 114 cross sections were analyzed. At baseline, plaques were unevenly distributed among the four groups: 48% of the plaques LWT>Smm were located at the proximal, left side of the aorta, 28% at the proximal right side, while the other 24% of the plaques were distally located. Statin treatment resulted for lesions with LWT> 3mm, in an average plaque regression of 0.37 mm (IO%, pdO.05). Overall, plaque regression was directly related to the baseline wall thickness (LWTregresslon=0.50'L~~~~~,,"~-1.33
[mm], ~~0.05) and multwariate analysis showed plaque location as an independent predlctor.
Conclusion
Stalin therapy Induces regression of the atherosclerotic lesions in the descending thoracic aorta and this effect is dependent on pre-existing plaque size and location. Since flow patterns distal of the aortic arch are very characteristic and localized, these data might indicate the therapeutic effect of statins are modulated by local hemodynamics. 11:45 a.m. expanded porphyrin that localizes in plaque and generates reactive oxygen species @OS) in the presence of reducing metabolites like ascorbate (Ax).
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Photopoint Photodynamic Therapyjor the Treatment of Atherosclerotic Plaques
Methods and
Results: To study the synergic effects of MGd and Asc on ATH, 42 rabbits were fed a 2% chol diet for 6 weeks (2 wks before and 4 wks after ~lrac balloon denudation), and then randomized to 6 groups: (1) Controls; (2) MGd (lOmg/kg i.v.); (3) Ax (0.5g/kg I.v.);
(4) Asc 4h prior to MGd; (5) MGd + ASC simultaneously; (6) Asc 4h after MGd. After 4 more wks on a normal diet, rabbits were sacrificed and aortic surface plaque (Sudan IV
